| Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised … CE Coles, CL Griffin, AM Kirby, J Titley, RK Agrawal, A Alhasso, ... The Lancet 390 (10099), 1048-1060, 2017 | 555 | 2017 |
| Ten-year results of FAST: a randomized controlled trial of 5-fraction whole-breast radiotherapy for early breast cancer AM Brunt, JS Haviland, M Sydenham, RK Agrawal, H Algurafi, A Alhasso, ... Journal of Clinical Oncology 38 (28), 3261, 2020 | 220 | 2020 |
| Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main … C Goldsmith, J Haviland, Y Tsang, M Sydenham, J Yarnold Radiotherapy and Oncology 100 (2), 236-240, 2011 | 88 | 2011 |
| A multi-institutional dosimetry audit of rotational intensity-modulated radiotherapy CH Clark, M Hussein, Y Tsang, R Thomas, D Wilkinson, G Bass, J Snaith, ... Radiotherapy and Oncology 113 (2), 272-278, 2014 | 72 | 2014 |
| FAST phase III RCT of radiotherapy hypofractionation for treatment of early breast cancer: 10-year results (CRUKE/04/015) AM Brunt, J Haviland, M Sydenham, H Algurafi, A Alhasso, P Bliss, ... International Journal of Radiation Oncology, Biology, Physics 102 (5), 1603-1604, 2018 | 60 | 2018 |
| A methodology for dosimetry audit of rotational radiotherapy using a commercial detector array M Hussein, Y Tsang, RAS Thomas, C Gouldstone, D Maughan, ... Radiotherapy and Oncology 108 (1), 78-85, 2013 | 51 | 2013 |
| The role of complexity metrics in a multi-institutional dosimetry audit of VMAT CK McGarry, CE Agnew, M Hussein, Y Tsang, A McWilliam, AR Hounsell, ... The British journal of radiology 89 (1057), 20150445, 2016 | 42 | 2016 |
| Advanced practice: an ESTRO RTTC position paper A Duffton, L Devlin, Y Tsang, M Mast, M Leech Technical Innovations and Patient Support in Radiation Oncology 10, 16-19, 2019 | 37 | 2019 |
| Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial) EM Donovan, L Ciurlionis, J Fairfoul, H James, H Mayles, S Manktelow, ... International Journal of Radiation Oncology* Biology* Physics 79 (4), 1064-1072, 2011 | 34 | 2011 |
| Assessment of contour variability in target volumes and organs at risk in lung cancer radiotherapy Y Tsang, P Hoskin, E Spezi, D Landau, J Lester, E Miles, J Conibear Technical Innovations & Patient Support in Radiation Oncology 10, 8-12, 2019 | 33 | 2019 |
| External beam radiation therapy (EBRT) and high-dose-rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: the impact of EBRT volume H Tharmalingam, Y Tsang, A Choudhury, R Alonzi, J Wylie, I Ahmed, ... International Journal of Radiation Oncology* Biology* Physics 106 (3), 525-533, 2020 | 30 | 2020 |
| Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom Y Tsang, L Ciurlionis, AM Kirby, I Locke, K Venables, JR Yarnold, J Titley, ... The British journal of radiology 88 (1056), 20150453, 2015 | 30 | 2015 |
| The use of log file analysis within VMAT audits CK McGarry, CE Agnew, M Hussein, Y Tsang, AR Hounsell, CH Clark The British journal of radiology 89 (1062), 20150489, 2016 | 29 | 2016 |
| Abstract GS4-05: Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in … CE Coles, CL Griffin, AM Kirby, JS Haviland, JC Titley, K Benstead, ... Cancer Research 79 (4_Supplement), GS4-05-GS4-05, 2019 | 28 | 2019 |
| Partial breast radiotherapy for women with early breast cancer: First results of local recurrence data for IMPORT LOW (CRUK/06/003) C Coles, R Agrawal, ML Ah-See, H Algurafi, A Alhasso, AM Brunt, C Chan, ... | 26 | 2016 |
| The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy Y Tsang, J Haviland, K Venables, J Yarnold, ... Radiotherapy and Oncology 104 (2), 143-147, 2012 | 26 | 2012 |
| Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study H Tharmalingam, Y Tsang, P Ostler, J Wylie, A Bahl, A Lydon, I Ahmed, ... Radiotherapy and Oncology 143, 95-100, 2020 | 24 | 2020 |
| Ultra-hypofractionated radiotherapy for low-and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapy YM Tsang, H Tharmalingam, K Belessiotis-Richards, S Armstrong, ... Radiotherapy and Oncology 158, 184-190, 2021 | 21 | 2021 |
| Comparing proton to photon radiotherapy plans: UK consensus guidance for reporting under uncertainty for clinical trials M Lowe, A Gosling, O Nicholas, T Underwood, E Miles, YC Chang, ... Clinical Oncology 32 (7), 459-466, 2020 | 21 | 2020 |
| An external dosimetry audit programme to credential static and rotational IMRT delivery for clinical trials quality assurance DJ Eaton, J Tyler, A Backshall, D Bernstein, A Carver, A Gasnier, ... Physica Medica 35, 25-30, 2017 | 21 | 2017 |
